Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 3
1992 4
1997 1
1998 1
1999 1
2000 1
2001 1
2002 1
2003 1
2005 1
2008 1
2009 1
2011 1
2012 1
2013 2
2014 2
2015 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co-mixture with recombinant human hyaluronidase: A phase 1 randomized trial.
Bass A, Plotka A, Mridha K, Sattler C, Kim AM, Plowchalk DR. Bass A, et al. Among authors: plowchalk dr. Health Sci Rep. 2018 Jul 18;1(9):e61. doi: 10.1002/hsr2.61. eCollection 2018 Sep. Health Sci Rep. 2018. PMID: 30623096 Free PMC article.
The nitrosation of nicotine: a kinetic study.
Caldwell WS, Greene JM, Plowchalk DR, deBethizy JD. Caldwell WS, et al. Among authors: plowchalk dr. Chem Res Toxicol. 1991 Sep-Oct;4(5):513-6. doi: 10.1021/tx00023a003. Chem Res Toxicol. 1991. PMID: 1793797 No abstract available.
An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.
Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, Owen TA, Li M, DaSilva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchalk D, Vukicevic S, Thompson DD. Paralkar VM, et al. Among authors: plowchalk d. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6736-40. doi: 10.1073/pnas.1037343100. Epub 2003 May 14. Proc Natl Acad Sci U S A. 2003. PMID: 12748385 Free PMC article.
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug.
Vieira ML, Kirby B, Ragueneau-Majlessi I, Galetin A, Chien JY, Einolf HJ, Fahmi OA, Fischer V, Fretland A, Grime K, Hall SD, Higgs R, Plowchalk D, Riley R, Seibert E, Skordos K, Snoeys J, Venkatakrishnan K, Waterhouse T, Obach RS, Berglund EG, Zhang L, Zhao P, Reynolds KS, Huang SM. Vieira ML, et al. Among authors: plowchalk d. Clin Pharmacol Ther. 2014 Feb;95(2):189-98. doi: 10.1038/clpt.2013.187. Epub 2013 Sep 18. Clin Pharmacol Ther. 2014. PMID: 24048277
26 results